Sound Clinical Strategies: Wwwwwh?

How asking the right questions during clinical development planning can prevent costly mistakes down the line   When a biopharma company, and its investors, get excited about a new molecule, it can be easy to dive straight into clinical development. The sooner...

Clinical Trials in Asia: Boom or Bust?

A recent article in Outsourcing Pharma examined the state of clinical trials in China, India and Japan, and whether the recent boom in clinical trials in Asia was likely to turn into a bust.  While we agree with most points in the article, my colleague, Barb Geiger,...

Changes to US API Import Strategies

Today, I was quoted widely in a story In-PharmaTechnologist.com published titled US API Imports for Clinical Trials Now Require Effective IND, Expert Says. The story came as a result of my recent “Outsourcing Clinical Supplies Manufacturing: Navigating US API Import...